Voyager Therapeutics (VYGR) analyst forecast and price target
Analyst forecast
Consensus of 11 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $25.00 | Aug 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 | Mar 17, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 from $30.00 | Nov 12, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Sep 15, 2025 |
| Wedbush | Maintained | Outperform | $8.00 from $9.00 | Aug 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Apr 8, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Mar 13, 2025 |
| Canaccord Genuity | Maintained | Buy | $12.00 from $14.00 | Mar 13, 2025 |
| Wedbush | Maintained | Outperform | — | Mar 12, 2025 |
| Wells Fargo | Maintained | Overweight | $10.00 from $12.00 | Mar 12, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | — | Mar 12, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Mar 3, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Jan 27, 2025 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | $5.73 | Jan 10, 2025 |
| Citigroup | Initiated Coverage | Buy | $12.00 | Dec 2, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Nov 14, 2024 |
| Canaccord Genuity | Maintained | Buy | $14.00 | Nov 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Oct 24, 2024 |
| Leerink Partners | Initiated Coverage | Outperform | $15.00 | Oct 16, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 | Aug 20, 2024 |
Frequently asked questions
Is VYGR a buy, sell, or hold?
Analysts covering Voyager Therapeutics currently average a Buy rating: 11 buy, 0 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on VYGR?
On Aug 10, 2026, HC Wainwright & Co. maintained Voyager Therapeutics at Buy with a price target of $25.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.